CA2146545A1 - Methodes et compositions utilisant la (s)-nitrendipine optiquement pure pour le traitement de l'hypertension, de l'angine et d'autres affections - Google Patents

Methodes et compositions utilisant la (s)-nitrendipine optiquement pure pour le traitement de l'hypertension, de l'angine et d'autres affections

Info

Publication number
CA2146545A1
CA2146545A1 CA002146545A CA2146545A CA2146545A1 CA 2146545 A1 CA2146545 A1 CA 2146545A1 CA 002146545 A CA002146545 A CA 002146545A CA 2146545 A CA2146545 A CA 2146545A CA 2146545 A1 CA2146545 A1 CA 2146545A1
Authority
CA
Canada
Prior art keywords
nitrendipine
amount
administered
pharmaceutically acceptable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002146545A
Other languages
English (en)
Inventor
Timothy J. Barberich
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2146545A1 publication Critical patent/CA2146545A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002146545A 1992-10-06 1993-10-05 Methodes et compositions utilisant la (s)-nitrendipine optiquement pure pour le traitement de l'hypertension, de l'angine et d'autres affections Abandoned CA2146545A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95720092A 1992-10-06 1992-10-06
US957,200 1992-10-06

Publications (1)

Publication Number Publication Date
CA2146545A1 true CA2146545A1 (fr) 1994-04-14

Family

ID=25499221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002146545A Abandoned CA2146545A1 (fr) 1992-10-06 1993-10-05 Methodes et compositions utilisant la (s)-nitrendipine optiquement pure pour le traitement de l'hypertension, de l'angine et d'autres affections

Country Status (5)

Country Link
EP (1) EP0663822A4 (fr)
JP (1) JPH08502263A (fr)
AU (1) AU5170393A (fr)
CA (1) CA2146545A1 (fr)
WO (1) WO1994007476A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4613496B2 (ja) * 2003-02-07 2011-01-19 味の素株式会社 不整脈治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
JPH0381262A (ja) * 1989-08-23 1991-04-05 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン系カルシウム拮抗薬の光学活性体の製造法

Also Published As

Publication number Publication date
EP0663822A1 (fr) 1995-07-26
EP0663822A4 (fr) 1997-04-23
WO1994007476A1 (fr) 1994-04-14
AU5170393A (en) 1994-04-26
JPH08502263A (ja) 1996-03-12

Similar Documents

Publication Publication Date Title
US6448275B2 (en) Methods for treating hypertension and angina using salts of optically pure (−) amplodipine
US5698558A (en) Methods for treating allergic disorders using optically pure (-) cetirizine
AU3147593A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
US5508279A (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia
WO1994006430A1 (fr) Procedes et compositions de traitement de troubles allergiques a l'aide de cetirizine (+) optiquement pure
US5571827A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5834496A (en) Methods for treating hypertension using optically pure S(-) felodipine
AU711231B2 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure S(-) nitrendipine
EP0663822A1 (fr) Procedes et compositions permettant de traiter l'hypertenson, les angines et d'autres affections au moyen de nitredipine s(-) optiquement pure
CA2125149A1 (fr) Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres affections par l'administration de s(-)felodipine optiquement pure
US5510352A (en) Methods of using (+) doxazosin for the treatment of hypertension
WO1994009783A1 (fr) Procedes et compositions contenant de la doxazosine (-) utilises dans le traitement de l'adenome prostatique et de l'atherosclerose
HK1029521A (en) Method and compositions for treating hypertensioin, angina and other disorders using optically pure (-) amlodipine.
AU2006200150A1 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
AU1354000A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
EP1614420A2 (fr) Traitment de l'hypertension, de l'angine de poitrine et d'autres troubles avec (-)amlodipine
AU1016900A (en) Methods and compositions for treating hypertension, angina, and other disorders using optically pures(-) felodipine
AU703690B2 (en) Methods for treating allergic disorders using optically pure (+)cetirizine
WO1994009782A1 (fr) Procedes et compositions de doxazosine (-) pour le traitement de l'hypertension
WO2005041969A1 (fr) Produit pharmaceutique comprenant un agoniste beta-2 adrenergique et un antagoniste du recepteur h1

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20001005